What are the differences between Molecular circulating tumor DNA (ctDNA) testing and minimal residual disease (MRD) testing? Now presenting Dr. @Joshua_Reuss! #LungCancer #TargetedTherapies #TrueOrFalse #Molecularprofiling #MRDTesting #ctDNATesting

🧬 Precision Insight for Prostate Cancer Care Serial liquid biopsies are changing how clinicians monitor metastatic castration-resistant prostate cancer. A large real-world study shows that androgen receptor (AR) alterations repeatedly appear across ARPIs, PARP inhibitors, and chemotherapy, and are linked to shorter survival and faster treatment failure. 🔗 Read full article at: ow.ly/kUvH50YmOEg By tracking circulating tumor DNA over time, researchers demonstrated that one-time genomic testing may miss critical, treatment-related molecular shifts. Real-time ctDNA monitoring offers a clearer picture of resistance biology and may support more timely, personalized treatment decisions for men with advanced disease. 👩‍⚕️👨‍⚕️ Relevant for oncologists, urologists, oncology nurses, and precision medicine teams. Credit: @umiamimedicine #AdvancedProstateCancer #Liquidbiopsy #ctDNAtesting #Androgenreceptor #Precisiononcology #ARpathwayinhibitors #Genomicprofiling #castration #prostatecancer #chemotherapy #cancercare #Tumor #CancerResearch #eMedEvents

Tune in to this @mendelspod episode featuring @benweinbergmd as he discusses the groundbreaking potential of #ctDNA testing. 🎧 Listen now: ow.ly/NnCg50SRavP #CancerResearch #ctDNATesting #Mendelspod #CRCSM

The Success of ctDNA Testing in Colorectal Cancer: Adham Jurdi, Natera mendelspod.com/p/the-success… @OncoJurdi @NateraOncology #ctDNAtesting #colorectalcancer

BIVDA's CEO Doris-Ann Williams has contributed to the launch of the new AHSN Network Genomic Innovation report. Take a look at it below 👇#personalisedmedicine #IVDs #ctDNAtesting